Senior Director, Quality Control
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Sarepta is at the forefront of genetic medicine, particularly in the treatment of Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs). With over 40 programs in various stages of development, including gene therapy, RNA, and gene editing, Sarepta launched its fourth therapy in 2023, marking a significant milestone as the first-ever gene therapy for Duchenne. The Senior Director overseeing internal Quality Control Testing will lead a team of approximately 50 QC analysts, managing an integrated testing schedule that supports both late-phase commercial manufacturing and early-phase clinical pipelines. This role is crucial in ensuring a continuous global supply of Sarepta's AAV gene therapies for neuromuscular disorders, requiring collaboration with Manufacturing, Quality Assurance, and Regulatory Affairs departments.
